Lori Deblasi, DPM
Foot Surgery · Fort Myers, FLNPI 1144216508
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Arthrex at 50.5% of the total. Reporting peaked in 2022 at $1,642 and has fallen 96.0% since, to $65 in 2025.
Across 34 payments — averaging $71.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Organogenesis Inc.$560
- Orthofix Medical, Inc.$248
- Amgen$178
- Smith+Nephew$58
- DJO, LLC$49
- plus $108 from 6 others
What the payments were for
- Food & beverage$1,22450%
- Education$1,20050%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 2 | $1,224 |
| Organogenesis Inc. | 13 | $560 |
| Orthofix Medical, Inc. | 2 | $248 |
| Amgen(2 entities) | 5 | $178 |
| Smith+Nephew | 3 | $58 |
| DJO, LLC | 2 | $49 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| AbbVie | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Physio-Stim$395
- PuraPly$364
- AccelStim$102
- KRYSTEXXA$101
How this compares
$2,424 in reported general payments places this provider in the 70th percentile of 107 foot surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 75 | $1,345 |
| Ketoconazole | 41 | $1,095 |
| Diclofenac Sodium | 41 | $1,076 |
| Terbinafine Hcl | 16 | $508 |
| Methylprednisolone | 69 | $406 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $248 |
| Cephalexin | 48 | $242 |
| Mupirocin | 41 | $236 |
| Doxycycline Hyclate | 14 | $226 |
| Meloxicam | 93 | $210 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $164 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Fort Myers
- Joseph GrilloFort Myers$7K
- Larry HodsonPanama City$413K
- Bret BrennanTampa$60K
- Bradley HerbstJacksonville$20K
- Amy DunetzAventura$14K
- Than Binh NguyenTampa$13K
- Orlando CedenoJupiter$13K
- Karen LeePembroke Pines$12K
- Nicole GortaireSt Augustine$11K
- Alix CharlesPlantation$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.